nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0355	0.0528	CbGbCtD
Docetaxel—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0328	0.0489	CbGbCtD
Docetaxel—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0306	0.0456	CbGbCtD
Docetaxel—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0269	0.04	CbGbCtD
Docetaxel—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0269	0.04	CbGbCtD
Docetaxel—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0227	0.0337	CbGbCtD
Docetaxel—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0199	0.0297	CbGbCtD
Docetaxel—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0199	0.0296	CbGbCtD
Docetaxel—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0199	0.0296	CbGbCtD
Docetaxel—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0199	0.0296	CbGbCtD
Docetaxel—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.018	0.0268	CbGbCtD
Docetaxel—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.018	0.0268	CbGbCtD
Docetaxel—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0261	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0261	CbGbCtD
Docetaxel—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0172	0.0257	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0225	CbGbCtD
Docetaxel—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0225	CbGbCtD
Docetaxel—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0148	0.022	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0219	CbGbCtD
Docetaxel—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0219	CbGbCtD
Docetaxel—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0145	0.0216	CbGbCtD
Docetaxel—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0133	0.0199	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0198	CbGbCtD
Docetaxel—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0198	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0198	CbGbCtD
Docetaxel—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0198	CbGbCtD
Docetaxel—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0131	0.0196	CbGbCtD
Docetaxel—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0131	0.0196	CbGbCtD
Docetaxel—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0114	0.0169	CbGbCtD
Docetaxel—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.011	0.0164	CbGbCtD
Docetaxel—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00997	0.0148	CbGbCtD
Docetaxel—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00997	0.0148	CbGbCtD
Docetaxel—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00946	0.0141	CbGbCtD
Docetaxel—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00856	0.0127	CbGbCtD
Docetaxel—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00739	0.011	CbGbCtD
Docetaxel—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00717	0.0107	CbGbCtD
Docetaxel—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00649	0.00966	CbGbCtD
Docetaxel—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00649	0.00966	CbGbCtD
Docetaxel—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00622	0.00926	CbGbCtD
Docetaxel—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00603	0.00898	CbGbCtD
Docetaxel—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00567	0.00844	CbGbCtD
Docetaxel—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00567	0.00844	CbGbCtD
Docetaxel—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00513	0.00763	CbGbCtD
Docetaxel—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00513	0.00763	CbGbCtD
Docetaxel—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00481	0.00716	CbGbCtD
Docetaxel—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00443	0.00659	CbGbCtD
Docetaxel—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0043	0.0064	CbGbCtD
Docetaxel—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00389	0.00579	CbGbCtD
Docetaxel—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00389	0.00579	CbGbCtD
Docetaxel—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00373	0.00555	CbGbCtD
Docetaxel—MAP2—nerve—acquired immunodeficiency syndrome	0.00207	0.023	CbGeAlD
Docetaxel—MAP4—blood plasma—acquired immunodeficiency syndrome	0.00199	0.022	CbGeAlD
Docetaxel—TUBB1—blood plasma—acquired immunodeficiency syndrome	0.00195	0.0216	CbGeAlD
Docetaxel—KIF11—blood—acquired immunodeficiency syndrome	0.00158	0.0175	CbGeAlD
Docetaxel—KIF11—bone marrow—acquired immunodeficiency syndrome	0.00153	0.017	CbGeAlD
Docetaxel—GHRHR—nervous system—acquired immunodeficiency syndrome	0.00151	0.0167	CbGeAlD
Docetaxel—KIF11—vagina—acquired immunodeficiency syndrome	0.00147	0.0162	CbGeAlD
Docetaxel—GHRHR—central nervous system—acquired immunodeficiency syndrome	0.00145	0.0161	CbGeAlD
Docetaxel—KIF11—lung—acquired immunodeficiency syndrome	0.00139	0.0154	CbGeAlD
Docetaxel—MAPT—retina—acquired immunodeficiency syndrome	0.00139	0.0154	CbGeAlD
Docetaxel—TUBB6—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.0012	0.363	CbGdCrCtD
Docetaxel—NR1I2—digestive system—acquired immunodeficiency syndrome	0.00117	0.013	CbGeAlD
Docetaxel—GHRHR—brain—acquired immunodeficiency syndrome	0.00115	0.0128	CbGeAlD
Docetaxel—MAP4—retina—acquired immunodeficiency syndrome	0.00109	0.0121	CbGeAlD
Docetaxel—KIF11—brain—acquired immunodeficiency syndrome	0.000982	0.0109	CbGeAlD
Docetaxel—MAP4—skin of body—acquired immunodeficiency syndrome	0.000957	0.0106	CbGeAlD
Docetaxel—KIF11—lymph node—acquired immunodeficiency syndrome	0.000948	0.0105	CbGeAlD
Docetaxel—MAPT—spinal cord—acquired immunodeficiency syndrome	0.000894	0.0099	CbGeAlD
Docetaxel—BCL2—skin of body—acquired immunodeficiency syndrome	0.00087	0.00963	CbGeAlD
Docetaxel—TUBB8—nervous system—acquired immunodeficiency syndrome	0.000867	0.00961	CbGeAlD
Docetaxel—MAP2—retina—acquired immunodeficiency syndrome	0.000858	0.00951	CbGeAlD
Docetaxel—TUBB8—central nervous system—acquired immunodeficiency syndrome	0.000835	0.00925	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—acquired immunodeficiency syndrome	0.000775	0.00858	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—acquired immunodeficiency syndrome	0.000775	0.00858	CbGeAlD
Docetaxel—KIF11—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000766	0.233	CbGdCrCtD
Docetaxel—TUBB3—digestive system—acquired immunodeficiency syndrome	0.000765	0.00848	CbGeAlD
Docetaxel—MAP4—digestive system—acquired immunodeficiency syndrome	0.000765	0.00848	CbGeAlD
Docetaxel—TUBB3—blood—acquired immunodeficiency syndrome	0.000729	0.00808	CbGeAlD
Docetaxel—MAP4—blood—acquired immunodeficiency syndrome	0.000729	0.00808	CbGeAlD
Docetaxel—TUBB1—blood—acquired immunodeficiency syndrome	0.000713	0.0079	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—acquired immunodeficiency syndrome	0.000704	0.0078	CbGeAlD
Docetaxel—KIF11—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000703	0.214	CbGdCrCtD
Docetaxel—MAP4—spinal cord—acquired immunodeficiency syndrome	0.000702	0.00778	CbGeAlD
Docetaxel—BCL2—digestive system—acquired immunodeficiency syndrome	0.000696	0.00771	CbGeAlD
Docetaxel—TUBB1—bone marrow—acquired immunodeficiency syndrome	0.00069	0.00764	CbGeAlD
Docetaxel—MAP4—vagina—acquired immunodeficiency syndrome	0.000676	0.00749	CbGeAlD
Docetaxel—TUBB4A—retina—acquired immunodeficiency syndrome	0.000663	0.00735	CbGeAlD
Docetaxel—TUBB8—brain—acquired immunodeficiency syndrome	0.000663	0.00734	CbGeAlD
Docetaxel—BCL2—blood—acquired immunodeficiency syndrome	0.000663	0.00734	CbGeAlD
Docetaxel—BCL2—bone marrow—acquired immunodeficiency syndrome	0.000641	0.0071	CbGeAlD
Docetaxel—TUBB2B—retina—acquired immunodeficiency syndrome	0.000641	0.0071	CbGeAlD
Docetaxel—TUBB3—lung—acquired immunodeficiency syndrome	0.000639	0.00708	CbGeAlD
Docetaxel—MAP4—lung—acquired immunodeficiency syndrome	0.000639	0.00708	CbGeAlD
Docetaxel—TUBB6—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000628	0.191	CbGdCrCtD
Docetaxel—MAP2—digestive system—acquired immunodeficiency syndrome	0.000603	0.00667	CbGeAlD
Docetaxel—MAP4—nervous system—acquired immunodeficiency syndrome	0.000592	0.00656	CbGeAlD
Docetaxel—TUBB3—nervous system—acquired immunodeficiency syndrome	0.000592	0.00656	CbGeAlD
Docetaxel—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000592	0.00655	CbGeAlD
Docetaxel—TUBB4A—skin of body—acquired immunodeficiency syndrome	0.000582	0.00645	CbGeAlD
Docetaxel—BCL2—lung—acquired immunodeficiency syndrome	0.000581	0.00644	CbGeAlD
Docetaxel—TUBB1—nervous system—acquired immunodeficiency syndrome	0.000579	0.00641	CbGeAlD
Docetaxel—MAPT—brain—acquired immunodeficiency syndrome	0.000575	0.00637	CbGeAlD
Docetaxel—MAP2—blood—acquired immunodeficiency syndrome	0.000574	0.00636	CbGeAlD
Docetaxel—EGFR—lung—acquired immunodeficiency syndrome	0.000574	0.00636	CbGeAlD
Docetaxel—TUBB3—central nervous system—acquired immunodeficiency syndrome	0.00057	0.00631	CbGeAlD
Docetaxel—MAP4—central nervous system—acquired immunodeficiency syndrome	0.00057	0.00631	CbGeAlD
Docetaxel—SLCO1B3—lung—acquired immunodeficiency syndrome	0.00056	0.0062	CbGeAlD
Docetaxel—TUBB1—central nervous system—acquired immunodeficiency syndrome	0.000557	0.00617	CbGeAlD
Docetaxel—MAPT—lymph node—acquired immunodeficiency syndrome	0.000556	0.00616	CbGeAlD
Docetaxel—MAP2—spinal cord—acquired immunodeficiency syndrome	0.000553	0.00613	CbGeAlD
Docetaxel—BCL2—nervous system—acquired immunodeficiency syndrome	0.000538	0.00596	CbGeAlD
Docetaxel—MAP2—vagina—acquired immunodeficiency syndrome	0.000532	0.00589	CbGeAlD
Docetaxel—TUBB2A—skin of body—acquired immunodeficiency syndrome	0.00053	0.00587	CbGeAlD
Docetaxel—TUBB6—skin of body—acquired immunodeficiency syndrome	0.000522	0.00579	CbGeAlD
Docetaxel—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000521	0.00577	CbGeAlD
Docetaxel—BCL2—central nervous system—acquired immunodeficiency syndrome	0.000518	0.00574	CbGeAlD
Docetaxel—TUBB4B—retina—acquired immunodeficiency syndrome	0.000517	0.00573	CbGeAlD
Docetaxel—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000517	0.00573	CbGeAlD
Docetaxel—MAP2—lung—acquired immunodeficiency syndrome	0.000503	0.00557	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—acquired immunodeficiency syndrome	0.000472	0.00522	CbGeAlD
Docetaxel—MAP2—nervous system—acquired immunodeficiency syndrome	0.000466	0.00516	CbGeAlD
Docetaxel—TUBB4A—digestive system—acquired immunodeficiency syndrome	0.000466	0.00516	CbGeAlD
Docetaxel—TUBB4B—skin of body—acquired immunodeficiency syndrome	0.000454	0.00503	CbGeAlD
Docetaxel—TUBB3—brain—acquired immunodeficiency syndrome	0.000452	0.00501	CbGeAlD
Docetaxel—MAP4—brain—acquired immunodeficiency syndrome	0.000452	0.00501	CbGeAlD
Docetaxel—TUBB2B—digestive system—acquired immunodeficiency syndrome	0.00045	0.00499	CbGeAlD
Docetaxel—MAP2—central nervous system—acquired immunodeficiency syndrome	0.000449	0.00497	CbGeAlD
Docetaxel—TUBB4A—blood—acquired immunodeficiency syndrome	0.000444	0.00491	CbGeAlD
Docetaxel—TUBB1—brain—acquired immunodeficiency syndrome	0.000442	0.0049	CbGeAlD
Docetaxel—MAP4—lymph node—acquired immunodeficiency syndrome	0.000437	0.00484	CbGeAlD
Docetaxel—TUBB4A—spinal cord—acquired immunodeficiency syndrome	0.000427	0.00473	CbGeAlD
Docetaxel—TUBB2A—digestive system—acquired immunodeficiency syndrome	0.000424	0.00469	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—acquired immunodeficiency syndrome	0.000423	0.00469	CbGeAlD
Docetaxel—TUBB6—digestive system—acquired immunodeficiency syndrome	0.000418	0.00463	CbGeAlD
Docetaxel—TUBB2B—spinal cord—acquired immunodeficiency syndrome	0.000413	0.00458	CbGeAlD
Docetaxel—BCL2—brain—acquired immunodeficiency syndrome	0.000411	0.00455	CbGeAlD
Docetaxel—EGFR—brain—acquired immunodeficiency syndrome	0.000406	0.0045	CbGeAlD
Docetaxel—TUBB—blood—acquired immunodeficiency syndrome	0.000406	0.00449	CbGeAlD
Docetaxel—TUBB2A—blood—acquired immunodeficiency syndrome	0.000404	0.00447	CbGeAlD
Docetaxel—TUBB6—blood—acquired immunodeficiency syndrome	0.000398	0.00441	CbGeAlD
Docetaxel—TUBB2B—vagina—acquired immunodeficiency syndrome	0.000398	0.0044	CbGeAlD
Docetaxel—BCL2—lymph node—acquired immunodeficiency syndrome	0.000397	0.0044	CbGeAlD
Docetaxel—EGFR—lymph node—acquired immunodeficiency syndrome	0.000393	0.00435	CbGeAlD
Docetaxel—TUBB—bone marrow—acquired immunodeficiency syndrome	0.000393	0.00435	CbGeAlD
Docetaxel—TUBB—spinal cord—acquired immunodeficiency syndrome	0.000391	0.00433	CbGeAlD
Docetaxel—TUBB2A—bone marrow—acquired immunodeficiency syndrome	0.000391	0.00433	CbGeAlD
Docetaxel—TUBB4A—lung—acquired immunodeficiency syndrome	0.000389	0.00431	CbGeAlD
Docetaxel—TUBB2A—spinal cord—acquired immunodeficiency syndrome	0.000389	0.00431	CbGeAlD
Docetaxel—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000388	0.0043	CbGeAlD
Docetaxel—TUBB6—bone marrow—acquired immunodeficiency syndrome	0.000385	0.00427	CbGeAlD
Docetaxel—TUBB6—spinal cord—acquired immunodeficiency syndrome	0.000384	0.00425	CbGeAlD
Docetaxel—TUBB—vagina—acquired immunodeficiency syndrome	0.000376	0.00417	CbGeAlD
Docetaxel—TUBB2B—lung—acquired immunodeficiency syndrome	0.000376	0.00416	CbGeAlD
Docetaxel—TUBB2A—vagina—acquired immunodeficiency syndrome	0.000374	0.00414	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.00037	0.0041	CbGeAlD
Docetaxel—TUBB6—vagina—acquired immunodeficiency syndrome	0.000369	0.00409	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—acquired immunodeficiency syndrome	0.000368	0.00407	CbGeAlD
Docetaxel—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000366	0.00405	CbGeAlD
Docetaxel—TUBB4B—digestive system—acquired immunodeficiency syndrome	0.000363	0.00402	CbGeAlD
Docetaxel—TUBB4A—nervous system—acquired immunodeficiency syndrome	0.00036	0.00399	CbGeAlD
Docetaxel—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.00036	0.00398	CbGeAlD
Docetaxel—MAP2—brain—acquired immunodeficiency syndrome	0.000356	0.00395	CbGeAlD
Docetaxel—TUBB—lung—acquired immunodeficiency syndrome	0.000356	0.00394	CbGeAlD
Docetaxel—TUBB2A—lung—acquired immunodeficiency syndrome	0.000354	0.00392	CbGeAlD
Docetaxel—TUBB6—lung—acquired immunodeficiency syndrome	0.000349	0.00387	CbGeAlD
Docetaxel—ABCC10—blood—acquired immunodeficiency syndrome	0.000349	0.00386	CbGeAlD
Docetaxel—TUBB2B—nervous system—acquired immunodeficiency syndrome	0.000348	0.00386	CbGeAlD
Docetaxel—TUBB4A—central nervous system—acquired immunodeficiency syndrome	0.000347	0.00384	CbGeAlD
Docetaxel—TUBB4B—blood—acquired immunodeficiency syndrome	0.000346	0.00383	CbGeAlD
Docetaxel—MAP2—lymph node—acquired immunodeficiency syndrome	0.000344	0.00381	CbGeAlD
Docetaxel—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000337	0.00374	CbGeAlD
Docetaxel—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000336	0.00372	CbGeAlD
Docetaxel—TUBB2B—central nervous system—acquired immunodeficiency syndrome	0.000335	0.00371	CbGeAlD
Docetaxel—TUBB4B—bone marrow—acquired immunodeficiency syndrome	0.000335	0.00371	CbGeAlD
Docetaxel—TUBB4B—spinal cord—acquired immunodeficiency syndrome	0.000333	0.00369	CbGeAlD
Docetaxel—TUBB2A—nervous system—acquired immunodeficiency syndrome	0.000328	0.00363	CbGeAlD
Docetaxel—TUBB6—nervous system—acquired immunodeficiency syndrome	0.000323	0.00358	CbGeAlD
Docetaxel—ABCC10—vagina—acquired immunodeficiency syndrome	0.000323	0.00358	CbGeAlD
Docetaxel—TUBB4B—vagina—acquired immunodeficiency syndrome	0.000321	0.00355	CbGeAlD
Docetaxel—TUBB2A—central nervous system—acquired immunodeficiency syndrome	0.000316	0.00349	CbGeAlD
Docetaxel—TUBB6—central nervous system—acquired immunodeficiency syndrome	0.000311	0.00345	CbGeAlD
Docetaxel—SLC22A7—brain—acquired immunodeficiency syndrome	0.000308	0.00341	CbGeAlD
Docetaxel—ABCC10—lung—acquired immunodeficiency syndrome	0.000306	0.00338	CbGeAlD
Docetaxel—TUBB4B—lung—acquired immunodeficiency syndrome	0.000303	0.00336	CbGeAlD
Docetaxel—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000294	0.00325	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000291	0.00323	CbGeAlD
Docetaxel—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000288	0.00319	CbGeAlD
Docetaxel—TUBB4B—nervous system—acquired immunodeficiency syndrome	0.000281	0.00311	CbGeAlD
Docetaxel—ABCC2—blood—acquired immunodeficiency syndrome	0.00028	0.0031	CbGeAlD
Docetaxel—TUBB4A—brain—acquired immunodeficiency syndrome	0.000275	0.00305	CbGeAlD
Docetaxel—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000275	0.00304	CbGeAlD
Docetaxel—CYP1B1—blood—acquired immunodeficiency syndrome	0.000274	0.00304	CbGeAlD
Docetaxel—TUBB4B—central nervous system—acquired immunodeficiency syndrome	0.000271	0.003	CbGeAlD
Docetaxel—TUBB2B—brain—acquired immunodeficiency syndrome	0.000266	0.00295	CbGeAlD
Docetaxel—TUBB4A—lymph node—acquired immunodeficiency syndrome	0.000266	0.00295	CbGeAlD
Docetaxel—TUBB2B—lymph node—acquired immunodeficiency syndrome	0.000257	0.00285	CbGeAlD
Docetaxel—TUBB—brain—acquired immunodeficiency syndrome	0.000252	0.00279	CbGeAlD
Docetaxel—TUBB2A—brain—acquired immunodeficiency syndrome	0.00025	0.00277	CbGeAlD
Docetaxel—TUBB6—brain—acquired immunodeficiency syndrome	0.000247	0.00274	CbGeAlD
Docetaxel—ABCC1—blood—acquired immunodeficiency syndrome	0.000247	0.00273	CbGeAlD
Docetaxel—TUBB—lymph node—acquired immunodeficiency syndrome	0.000243	0.00269	CbGeAlD
Docetaxel—TUBB2A—lymph node—acquired immunodeficiency syndrome	0.000242	0.00268	CbGeAlD
Docetaxel—CYP1B1—lung—acquired immunodeficiency syndrome	0.00024	0.00266	CbGeAlD
Docetaxel—TUBB6—lymph node—acquired immunodeficiency syndrome	0.000239	0.00264	CbGeAlD
Docetaxel—ABCC1—vagina—acquired immunodeficiency syndrome	0.000229	0.00253	CbGeAlD
Docetaxel—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000223	0.00246	CbGeAlD
Docetaxel—ABCC10—brain—acquired immunodeficiency syndrome	0.000216	0.0024	CbGeAlD
Docetaxel—ABCC1—lung—acquired immunodeficiency syndrome	0.000216	0.00239	CbGeAlD
Docetaxel—TUBB4B—brain—acquired immunodeficiency syndrome	0.000215	0.00238	CbGeAlD
Docetaxel—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000214	0.00237	CbGeAlD
Docetaxel—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000209	0.00231	CbGeAlD
Docetaxel—TUBB4B—lymph node—acquired immunodeficiency syndrome	0.000208	0.0023	CbGeAlD
Docetaxel—ABCG2—blood—acquired immunodeficiency syndrome	0.000204	0.00226	CbGeAlD
Docetaxel—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000199	0.0022	CbGeAlD
Docetaxel—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000198	0.00219	CbGeAlD
Docetaxel—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000197	0.00218	CbGeAlD
Docetaxel—CYP3A5—blood—acquired immunodeficiency syndrome	0.000189	0.0021	CbGeAlD
Docetaxel—ABCG2—vagina—acquired immunodeficiency syndrome	0.000189	0.0021	CbGeAlD
Docetaxel—ABCG2—lung—acquired immunodeficiency syndrome	0.000179	0.00198	CbGeAlD
Docetaxel—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000176	0.00195	CbGeAlD
Docetaxel—CYP1B1—brain—acquired immunodeficiency syndrome	0.00017	0.00188	CbGeAlD
Docetaxel—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000168	0.00186	CbGeAlD
Docetaxel—CYP3A5—lung—acquired immunodeficiency syndrome	0.000166	0.00184	CbGeAlD
Docetaxel—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000164	0.00182	CbGeAlD
Docetaxel—ABCC1—brain—acquired immunodeficiency syndrome	0.000153	0.00169	CbGeAlD
Docetaxel—ABCB1—retina—acquired immunodeficiency syndrome	0.00015	0.00167	CbGeAlD
Docetaxel—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000149	0.00165	CbGeAlD
Docetaxel—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000148	0.00164	CbGeAlD
Docetaxel—CYP3A4—blood—acquired immunodeficiency syndrome	0.000142	0.00157	CbGeAlD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—acquired immunodeficiency syndrome	0.000131	0.00386	CbGpPWpGaD
Docetaxel—ABCG2—brain—acquired immunodeficiency syndrome	0.000127	0.0014	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000126	0.0037	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000125	0.00369	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000123	0.00361	CbGpPWpGaD
Docetaxel—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000122	0.00136	CbGeAlD
Docetaxel—EGFR—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.000122	0.0036	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CCR2—acquired immunodeficiency syndrome	0.000122	0.0036	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—acquired immunodeficiency syndrome	0.000121	0.00356	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00012	0.00354	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00012	0.00354	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000119	0.00349	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000118	0.00347	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000118	0.00347	CbGpPWpGaD
Docetaxel—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000115	0.00128	CbGeAlD
Docetaxel—EGFR—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000115	0.0034	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000114	0.00335	CbGpPWpGaD
Docetaxel—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000111	0.00123	CbGeAlD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00011	0.00324	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IFNA1—acquired immunodeficiency syndrome	0.00011	0.00324	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000109	0.0032	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—TNF—acquired immunodeficiency syndrome	0.000109	0.0032	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000107	0.00315	CbGpPWpGaD
Docetaxel—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000107	0.00118	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00315	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00315	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD79A—acquired immunodeficiency syndrome	0.000107	0.00314	CbGpPWpGaD
Docetaxel—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000106	0.00117	CbGeAlD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000105	0.0031	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000104	0.00305	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000103	0.00302	CbGpPWpGaD
Docetaxel—ABCB1—blood—acquired immunodeficiency syndrome	0.000101	0.00111	CbGeAlD
Docetaxel—EGFR—GRB2 events in EGFR signaling—IL6—acquired immunodeficiency syndrome	0.0001	0.00296	CbGpPWpGaD
Docetaxel—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	9.96e-05	0.000496	CcSEcCtD
Docetaxel—Hypertension—Ritonavir—acquired immunodeficiency syndrome	9.95e-05	0.000495	CcSEcCtD
Docetaxel—Syncope—Saquinavir—acquired immunodeficiency syndrome	9.94e-05	0.000495	CcSEcCtD
Docetaxel—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	9.93e-05	0.000494	CcSEcCtD
Docetaxel—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	9.92e-05	0.000494	CcSEcCtD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	9.9e-05	0.00292	CbGpPWpGaD
Docetaxel—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	9.9e-05	0.000493	CcSEcCtD
Docetaxel—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	9.89e-05	0.000493	CcSEcCtD
Docetaxel—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	9.88e-05	0.000492	CcSEcCtD
Docetaxel—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	9.88e-05	0.000492	CcSEcCtD
Docetaxel—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.86e-05	0.000491	CcSEcCtD
Docetaxel—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.84e-05	0.00049	CcSEcCtD
Docetaxel—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.84e-05	0.00049	CcSEcCtD
Docetaxel—Chest pain—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.000489	CcSEcCtD
Docetaxel—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.000489	CcSEcCtD
Docetaxel—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.000489	CcSEcCtD
Docetaxel—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.78e-05	0.000487	CcSEcCtD
Docetaxel—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000487	CcSEcCtD
Docetaxel—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.000485	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.74e-05	0.000485	CcSEcCtD
Docetaxel—ABCB1—bone marrow—acquired immunodeficiency syndrome	9.74e-05	0.00108	CbGeAlD
Docetaxel—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.000484	CcSEcCtD
Docetaxel—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.7e-05	0.000483	CcSEcCtD
Docetaxel—ABCB1—spinal cord—acquired immunodeficiency syndrome	9.7e-05	0.00107	CbGeAlD
Docetaxel—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.7e-05	0.000483	CcSEcCtD
Docetaxel—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.69e-05	0.000483	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.000482	CcSEcCtD
Docetaxel—Cough—Saquinavir—acquired immunodeficiency syndrome	9.68e-05	0.000482	CcSEcCtD
Docetaxel—EGFR—SHC1 events in EGFR signaling—IL6—acquired immunodeficiency syndrome	9.67e-05	0.00285	CbGpPWpGaD
Docetaxel—Constipation—Indinavir—acquired immunodeficiency syndrome	9.62e-05	0.000479	CcSEcCtD
Docetaxel—Pain—Indinavir—acquired immunodeficiency syndrome	9.62e-05	0.000479	CcSEcCtD
Docetaxel—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.61e-05	0.000479	CcSEcCtD
Docetaxel—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.61e-05	0.000479	CcSEcCtD
Docetaxel—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.59e-05	0.000478	CcSEcCtD
Docetaxel—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.57e-05	0.000477	CcSEcCtD
Docetaxel—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.56e-05	0.000476	CcSEcCtD
Docetaxel—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.56e-05	0.000476	CcSEcCtD
Docetaxel—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.55e-05	0.000476	CcSEcCtD
Docetaxel—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.54e-05	0.000475	CcSEcCtD
Docetaxel—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.52e-05	0.000474	CcSEcCtD
Docetaxel—Nausea—Didanosine—acquired immunodeficiency syndrome	9.52e-05	0.000474	CcSEcCtD
Docetaxel—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000473	CcSEcCtD
Docetaxel—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000473	CcSEcCtD
Docetaxel—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000472	CcSEcCtD
Docetaxel—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.47e-05	0.000472	CcSEcCtD
Docetaxel—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.47e-05	0.000472	CcSEcCtD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—TNF—acquired immunodeficiency syndrome	9.47e-05	0.00279	CbGpPWpGaD
Docetaxel—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.45e-05	0.000471	CcSEcCtD
Docetaxel—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.00047	CcSEcCtD
Docetaxel—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.00047	CcSEcCtD
Docetaxel—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.00047	CcSEcCtD
Docetaxel—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.000468	CcSEcCtD
Docetaxel—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.38e-05	0.000467	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.38e-05	0.000467	CcSEcCtD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	9.36e-05	0.00276	CbGpPWpGaD
Docetaxel—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.35e-05	0.000466	CcSEcCtD
Docetaxel—ABCB1—vagina—acquired immunodeficiency syndrome	9.33e-05	0.00103	CbGeAlD
Docetaxel—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000463	CcSEcCtD
Docetaxel—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.27e-05	0.000462	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.000461	CcSEcCtD
Docetaxel—Shock—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000461	CcSEcCtD
Docetaxel—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.24e-05	0.00046	CcSEcCtD
Docetaxel—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.23e-05	0.00046	CcSEcCtD
Docetaxel—Cough—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.00046	CcSEcCtD
Docetaxel—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.23e-05	0.00046	CcSEcCtD
Docetaxel—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.22e-05	0.000459	CcSEcCtD
Docetaxel—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.21e-05	0.000459	CcSEcCtD
Docetaxel—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.2e-05	0.000458	CcSEcCtD
Docetaxel—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.2e-05	0.000458	CcSEcCtD
Docetaxel—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.2e-05	0.000458	CcSEcCtD
Docetaxel—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.18e-05	0.000457	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.17e-05	0.000457	CcSEcCtD
Docetaxel—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000457	CcSEcCtD
Docetaxel—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.16e-05	0.000456	CcSEcCtD
Docetaxel—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.16e-05	0.000456	CcSEcCtD
Docetaxel—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.13e-05	0.000455	CcSEcCtD
Docetaxel—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.13e-05	0.000455	CcSEcCtD
Docetaxel—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000455	CcSEcCtD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	9.12e-05	0.00269	CbGpPWpGaD
Docetaxel—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.09e-05	0.000453	CcSEcCtD
Docetaxel—Pain—Efavirenz—acquired immunodeficiency syndrome	9.09e-05	0.000453	CcSEcCtD
Docetaxel—Rash—Nevirapine—acquired immunodeficiency syndrome	9.09e-05	0.000453	CcSEcCtD
Docetaxel—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.08e-05	0.000452	CcSEcCtD
Docetaxel—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.07e-05	0.000452	CcSEcCtD
Docetaxel—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.06e-05	0.000452	CcSEcCtD
Docetaxel—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000451	CcSEcCtD
Docetaxel—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.04e-05	0.00045	CcSEcCtD
Docetaxel—Headache—Nevirapine—acquired immunodeficiency syndrome	9.03e-05	0.00045	CcSEcCtD
Docetaxel—NR1I2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	9.03e-05	0.00266	CbGpPWpGaD
Docetaxel—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.01e-05	0.000449	CcSEcCtD
Docetaxel—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.01e-05	0.000449	CcSEcCtD
Docetaxel—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.01e-05	0.000449	CcSEcCtD
Docetaxel—Infection—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.000448	CcSEcCtD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	8.97e-05	0.00264	CbGpPWpGaD
Docetaxel—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.96e-05	0.000446	CcSEcCtD
Docetaxel—GHRHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.95e-05	0.00264	CbGpPWpGaD
Docetaxel—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.95e-05	0.000446	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.94e-05	0.000446	CcSEcCtD
Docetaxel—Shock—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000444	CcSEcCtD
Docetaxel—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.89e-05	0.000443	CcSEcCtD
Docetaxel—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.89e-05	0.000443	CcSEcCtD
Docetaxel—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.88e-05	0.000442	CcSEcCtD
Docetaxel—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.87e-05	0.000442	CcSEcCtD
Docetaxel—BCL2—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	8.86e-05	0.00261	CbGpPWpGaD
Docetaxel—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000441	CcSEcCtD
Docetaxel—EGFR—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	8.85e-05	0.00261	CbGpPWpGaD
Docetaxel—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.85e-05	0.000441	CcSEcCtD
Docetaxel—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.84e-05	0.00044	CcSEcCtD
Docetaxel—ABCB1—lung—acquired immunodeficiency syndrome	8.82e-05	0.000977	CbGeAlD
Docetaxel—GHRHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.82e-05	0.0026	CbGpPWpGaD
Docetaxel—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	8.81e-05	0.000439	CcSEcCtD
Docetaxel—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.8e-05	0.000438	CcSEcCtD
Docetaxel—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.79e-05	0.000438	CcSEcCtD
Docetaxel—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.79e-05	0.000438	CcSEcCtD
Docetaxel—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000438	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.000437	CcSEcCtD
Docetaxel—Rash—Stavudine—acquired immunodeficiency syndrome	8.77e-05	0.000437	CcSEcCtD
Docetaxel—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.77e-05	0.000437	CcSEcCtD
Docetaxel—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.77e-05	0.000437	CcSEcCtD
Docetaxel—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.76e-05	0.000436	CcSEcCtD
Docetaxel—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.74e-05	0.000436	CcSEcCtD
Docetaxel—Headache—Stavudine—acquired immunodeficiency syndrome	8.72e-05	0.000434	CcSEcCtD
Docetaxel—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.72e-05	0.000434	CcSEcCtD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	8.71e-05	0.00257	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	8.71e-05	0.00257	CbGpPWpGaD
Docetaxel—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000434	CcSEcCtD
Docetaxel—KIF11—Immune System—CD40LG—acquired immunodeficiency syndrome	8.7e-05	0.00256	CbGpPWpGaD
Docetaxel—Pain—Delavirdine—acquired immunodeficiency syndrome	8.7e-05	0.000433	CcSEcCtD
Docetaxel—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.7e-05	0.000433	CcSEcCtD
Docetaxel—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.69e-05	0.000433	CcSEcCtD
Docetaxel—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.68e-05	0.000432	CcSEcCtD
Docetaxel—KIF11—Hemostasis—IL2—acquired immunodeficiency syndrome	8.67e-05	0.00255	CbGpPWpGaD
Docetaxel—Rash—Abacavir—acquired immunodeficiency syndrome	8.64e-05	0.000431	CcSEcCtD
Docetaxel—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.64e-05	0.00043	CcSEcCtD
Docetaxel—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.00043	CcSEcCtD
Docetaxel—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.00043	CcSEcCtD
Docetaxel—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.63e-05	0.00043	CcSEcCtD
Docetaxel—KIF11—Immune System—CSF2—acquired immunodeficiency syndrome	8.61e-05	0.00253	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD8A—acquired immunodeficiency syndrome	8.61e-05	0.00253	CbGpPWpGaD
Docetaxel—Headache—Abacavir—acquired immunodeficiency syndrome	8.59e-05	0.000428	CcSEcCtD
Docetaxel—Infection—Lamivudine—acquired immunodeficiency syndrome	8.58e-05	0.000427	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.000427	CcSEcCtD
Docetaxel—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.56e-05	0.000426	CcSEcCtD
Docetaxel—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.56e-05	0.000426	CcSEcCtD
Docetaxel—EGFR—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	8.53e-05	0.00251	CbGpPWpGaD
Docetaxel—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.5e-05	0.000424	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	8.5e-05	0.0025	CbGpPWpGaD
Docetaxel—Shock—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000423	CcSEcCtD
Docetaxel—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000422	CcSEcCtD
Docetaxel—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.46e-05	0.000421	CcSEcCtD
Docetaxel—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000421	CcSEcCtD
Docetaxel—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.44e-05	0.000421	CcSEcCtD
Docetaxel—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.4e-05	0.000418	CcSEcCtD
Docetaxel—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.4e-05	0.000418	CcSEcCtD
Docetaxel—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.000418	CcSEcCtD
Docetaxel—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.38e-05	0.000418	CcSEcCtD
Docetaxel—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.38e-05	0.000417	CcSEcCtD
Docetaxel—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.000416	CcSEcCtD
Docetaxel—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.31e-05	0.000414	CcSEcCtD
Docetaxel—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.29e-05	0.000413	CcSEcCtD
Docetaxel—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.29e-05	0.000413	CcSEcCtD
Docetaxel—KIF11—Immune System—HLA-B—acquired immunodeficiency syndrome	8.28e-05	0.00244	CbGpPWpGaD
Docetaxel—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.28e-05	0.000412	CcSEcCtD
Docetaxel—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.28e-05	0.000412	CcSEcCtD
Docetaxel—Nausea—Stavudine—acquired immunodeficiency syndrome	8.27e-05	0.000412	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.25e-05	0.000411	CcSEcCtD
Docetaxel—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.23e-05	0.00041	CcSEcCtD
Docetaxel—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.19e-05	0.000408	CcSEcCtD
Docetaxel—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.17e-05	0.000407	CcSEcCtD
Docetaxel—ABCB1—nervous system—acquired immunodeficiency syndrome	8.17e-05	0.000905	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	8.15e-05	0.0024	CbGpPWpGaD
Docetaxel—Nausea—Abacavir—acquired immunodeficiency syndrome	8.14e-05	0.000406	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.13e-05	0.00239	CbGpPWpGaD
Docetaxel—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.000405	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.000404	CcSEcCtD
Docetaxel—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.11e-05	0.000404	CcSEcCtD
Docetaxel—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.000402	CcSEcCtD
Docetaxel—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.07e-05	0.000402	CcSEcCtD
Docetaxel—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.07e-05	0.000402	CcSEcCtD
Docetaxel—GHRHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.07e-05	0.00238	CbGpPWpGaD
Docetaxel—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000401	CcSEcCtD
Docetaxel—Pain—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000401	CcSEcCtD
Docetaxel—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000401	CcSEcCtD
Docetaxel—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.0004	CcSEcCtD
Docetaxel—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.0004	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.01e-05	0.00236	CbGpPWpGaD
Docetaxel—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8e-05	0.000398	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	7.99e-05	0.00235	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ACTG1—acquired immunodeficiency syndrome	7.98e-05	0.00235	CbGpPWpGaD
Docetaxel—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.97e-05	0.000397	CcSEcCtD
Docetaxel—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.96e-05	0.000396	CcSEcCtD
Docetaxel—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.87e-05	0.000392	CcSEcCtD
Docetaxel—ABCB1—central nervous system—acquired immunodeficiency syndrome	7.87e-05	0.000871	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.000392	CcSEcCtD
Docetaxel—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.83e-05	0.00039	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000389	CcSEcCtD
Docetaxel—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.81e-05	0.000389	CcSEcCtD
Docetaxel—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.8e-05	0.000389	CcSEcCtD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00229	CbGpPWpGaD
Docetaxel—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000386	CcSEcCtD
Docetaxel—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.75e-05	0.000386	CcSEcCtD
Docetaxel—Pain—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000386	CcSEcCtD
Docetaxel—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000386	CcSEcCtD
Docetaxel—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.7e-05	0.000383	CcSEcCtD
Docetaxel—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.7e-05	0.000383	CcSEcCtD
Docetaxel—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.69e-05	0.000383	CcSEcCtD
Docetaxel—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.69e-05	0.000383	CcSEcCtD
Docetaxel—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000382	CcSEcCtD
Docetaxel—Rash—Zidovudine—acquired immunodeficiency syndrome	7.63e-05	0.00038	CcSEcCtD
Docetaxel—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.00038	CcSEcCtD
Docetaxel—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.62e-05	0.000379	CcSEcCtD
Docetaxel—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.6e-05	0.000379	CcSEcCtD
Docetaxel—EGFR—SHP2 signaling—IL2—acquired immunodeficiency syndrome	7.58e-05	0.00223	CbGpPWpGaD
Docetaxel—Headache—Zidovudine—acquired immunodeficiency syndrome	7.58e-05	0.000377	CcSEcCtD
Docetaxel—EGFR—GRB2 events in ERBB2 signaling—IL6—acquired immunodeficiency syndrome	7.55e-05	0.00222	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	7.54e-05	0.00222	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.53e-05	0.00222	CbGpPWpGaD
Docetaxel—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.52e-05	0.000375	CcSEcCtD
Docetaxel—EGFR—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	7.51e-05	0.00221	CbGpPWpGaD
Docetaxel—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.51e-05	0.000374	CcSEcCtD
Docetaxel—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.49e-05	0.000373	CcSEcCtD
Docetaxel—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.46e-05	0.000371	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000371	CcSEcCtD
Docetaxel—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.44e-05	0.000371	CcSEcCtD
Docetaxel—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.44e-05	0.00037	CcSEcCtD
Docetaxel—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.00037	CcSEcCtD
Docetaxel—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.00037	CcSEcCtD
Docetaxel—BCL2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	7.43e-05	0.00219	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.43e-05	0.00219	CbGpPWpGaD
Docetaxel—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.000369	CcSEcCtD
Docetaxel—Pain—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000368	CcSEcCtD
Docetaxel—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000368	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.33e-05	0.00216	CbGpPWpGaD
Docetaxel—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.3e-05	0.000363	CcSEcCtD
Docetaxel—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.27e-05	0.000362	CcSEcCtD
Docetaxel—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.19e-05	0.000358	CcSEcCtD
Docetaxel—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.18e-05	0.000358	CcSEcCtD
Docetaxel—EGFR—SHC1 events in ERBB2 signaling—IL6—acquired immunodeficiency syndrome	7.17e-05	0.00211	CbGpPWpGaD
Docetaxel—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000356	CcSEcCtD
Docetaxel—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000356	CcSEcCtD
Docetaxel—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.15e-05	0.000356	CcSEcCtD
Docetaxel—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000354	CcSEcCtD
Docetaxel—Rash—Indinavir—acquired immunodeficiency syndrome	7.09e-05	0.000353	CcSEcCtD
Docetaxel—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.09e-05	0.000353	CcSEcCtD
Docetaxel—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000352	CcSEcCtD
Docetaxel—Headache—Indinavir—acquired immunodeficiency syndrome	7.05e-05	0.000351	CcSEcCtD
Docetaxel—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.03e-05	0.00035	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	6.99e-05	0.00206	CbGpPWpGaD
Docetaxel—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.96e-05	0.000347	CcSEcCtD
Docetaxel—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	6.94e-05	0.00204	CbGpPWpGaD
Docetaxel—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.93e-05	0.000345	CcSEcCtD
Docetaxel—MAPT—Apoptosis—TNF—acquired immunodeficiency syndrome	6.92e-05	0.00204	CbGpPWpGaD
Docetaxel—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.00034	CcSEcCtD
Docetaxel—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.00034	CcSEcCtD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	6.82e-05	0.00201	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.82e-05	0.00201	CbGpPWpGaD
Docetaxel—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.76e-05	0.000337	CcSEcCtD
Docetaxel—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.000336	CcSEcCtD
Docetaxel—EGFR—B Cell Activation—CD79A—acquired immunodeficiency syndrome	6.74e-05	0.00199	CbGpPWpGaD
Docetaxel—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.000335	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.72e-05	0.00198	CbGpPWpGaD
Docetaxel—Rash—Efavirenz—acquired immunodeficiency syndrome	6.7e-05	0.000334	CcSEcCtD
Docetaxel—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.000333	CcSEcCtD
Docetaxel—Nausea—Indinavir—acquired immunodeficiency syndrome	6.68e-05	0.000333	CcSEcCtD
Docetaxel—EGFR—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	6.67e-05	0.00197	CbGpPWpGaD
Docetaxel—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.67e-05	0.000332	CcSEcCtD
Docetaxel—Headache—Efavirenz—acquired immunodeficiency syndrome	6.66e-05	0.000332	CcSEcCtD
Docetaxel—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000331	CcSEcCtD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	6.64e-05	0.00196	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.64e-05	0.00196	CbGpPWpGaD
Docetaxel—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000323	CcSEcCtD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	6.48e-05	0.00191	CbGpPWpGaD
Docetaxel—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.47e-05	0.000322	CcSEcCtD
Docetaxel—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.00032	CcSEcCtD
Docetaxel—Rash—Delavirdine—acquired immunodeficiency syndrome	6.41e-05	0.000319	CcSEcCtD
Docetaxel—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.41e-05	0.000319	CcSEcCtD
Docetaxel—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000319	CcSEcCtD
Docetaxel—Headache—Delavirdine—acquired immunodeficiency syndrome	6.37e-05	0.000317	CcSEcCtD
Docetaxel—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000317	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.31e-05	0.00186	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.31e-05	0.00186	CbGpPWpGaD
Docetaxel—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.31e-05	0.000314	CcSEcCtD
Docetaxel—ABCB1—brain—acquired immunodeficiency syndrome	6.25e-05	0.000692	CbGeAlD
Docetaxel—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.00031	CcSEcCtD
Docetaxel—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000309	CcSEcCtD
Docetaxel—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000308	CcSEcCtD
Docetaxel—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.11e-05	0.000304	CcSEcCtD
Docetaxel—EGFR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	6.1e-05	0.0018	CbGpPWpGaD
Docetaxel—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000301	CcSEcCtD
Docetaxel—ABCB1—lymph node—acquired immunodeficiency syndrome	6.04e-05	0.000668	CbGeAlD
Docetaxel—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.000298	CcSEcCtD
Docetaxel—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000298	CcSEcCtD
Docetaxel—Rash—Ritonavir—acquired immunodeficiency syndrome	5.93e-05	0.000295	CcSEcCtD
Docetaxel—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000295	CcSEcCtD
Docetaxel—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000294	CcSEcCtD
Docetaxel—Headache—Ritonavir—acquired immunodeficiency syndrome	5.89e-05	0.000293	CcSEcCtD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.85e-05	0.00172	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	5.76e-05	0.0017	CbGpPWpGaD
Docetaxel—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.75e-05	0.000287	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	5.72e-05	0.00168	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	5.72e-05	0.00168	CbGpPWpGaD
Docetaxel—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000284	CcSEcCtD
Docetaxel—Rash—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000284	CcSEcCtD
Docetaxel—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.000284	CcSEcCtD
Docetaxel—EGFR—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	5.69e-05	0.00168	CbGpPWpGaD
Docetaxel—Headache—Saquinavir—acquired immunodeficiency syndrome	5.67e-05	0.000282	CcSEcCtD
Docetaxel—EGFR—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	5.65e-05	0.00166	CbGpPWpGaD
Docetaxel—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.59e-05	0.000278	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	5.56e-05	0.00164	CbGpPWpGaD
Docetaxel—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.000273	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	5.48e-05	0.00161	CbGpPWpGaD
Docetaxel—Rash—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000271	CcSEcCtD
Docetaxel—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000271	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	5.44e-05	0.0016	CbGpPWpGaD
Docetaxel—Headache—Lamivudine—acquired immunodeficiency syndrome	5.41e-05	0.000269	CcSEcCtD
Docetaxel—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.38e-05	0.000268	CcSEcCtD
Docetaxel—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000255	CcSEcCtD
Docetaxel—KIF11—Immune System—IFNG—acquired immunodeficiency syndrome	5.12e-05	0.00151	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	5.03e-05	0.00148	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5e-05	0.00147	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ACTG1—acquired immunodeficiency syndrome	4.95e-05	0.00146	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—acquired immunodeficiency syndrome	4.94e-05	0.00146	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	4.93e-05	0.00145	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	4.9e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	4.83e-05	0.00142	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.8e-05	0.00141	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.73e-05	0.00139	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	4.69e-05	0.00138	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.66e-05	0.00137	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2—acquired immunodeficiency syndrome	4.55e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IL6—acquired immunodeficiency syndrome	4.45e-05	0.00131	CbGpPWpGaD
Docetaxel—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.45e-05	0.00131	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.33e-05	0.00127	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	4.29e-05	0.00126	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	4.25e-05	0.00125	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.23e-05	0.00125	CbGpPWpGaD
Docetaxel—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.22e-05	0.00124	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MBL2—acquired immunodeficiency syndrome	4.13e-05	0.00122	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	4.08e-05	0.0012	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MBL2—acquired immunodeficiency syndrome	4.07e-05	0.0012	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	3.94e-05	0.00116	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.89e-05	0.00115	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	3.71e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.7e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.67e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.6e-05	0.00106	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	3.6e-05	0.00106	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	3.59e-05	0.00106	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	3.55e-05	0.00105	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.47e-05	0.00102	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.36e-05	0.00099	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.35e-05	0.000987	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.34e-05	0.000984	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	3.31e-05	0.000974	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CCR2—acquired immunodeficiency syndrome	3.24e-05	0.000954	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CCR2—acquired immunodeficiency syndrome	3.19e-05	0.00094	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.16e-05	0.000932	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.16e-05	0.000932	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	3.13e-05	0.000921	CbGpPWpGaD
Docetaxel—EGFR—Disease—CCNT1—acquired immunodeficiency syndrome	3.12e-05	0.000918	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.05e-05	0.0009	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.05e-05	0.000898	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.02e-05	0.00089	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.99e-05	0.00088	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.96e-05	0.000871	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ACTG1—acquired immunodeficiency syndrome	2.93e-05	0.000862	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	2.92e-05	0.000859	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.89e-05	0.000852	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.87e-05	0.000846	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD79A—acquired immunodeficiency syndrome	2.79e-05	0.000822	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	2.72e-05	0.000801	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL6—acquired immunodeficiency syndrome	2.67e-05	0.000787	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.6e-05	0.000765	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.57e-05	0.000757	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	2.52e-05	0.000743	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.5e-05	0.000736	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000733	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MBL2—acquired immunodeficiency syndrome	2.41e-05	0.000709	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.38e-05	0.0007	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	2.36e-05	0.000694	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.28e-05	0.000673	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD40LG—acquired immunodeficiency syndrome	2.27e-05	0.00067	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.26e-05	0.000665	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.26e-05	0.000665	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—acquired immunodeficiency syndrome	2.25e-05	0.000662	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CSF2—acquired immunodeficiency syndrome	2.25e-05	0.000662	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.22e-05	0.000653	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	2.22e-05	0.000653	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.2e-05	0.000647	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	2.19e-05	0.000646	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	2.19e-05	0.000645	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.18e-05	0.000643	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.18e-05	0.000643	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.18e-05	0.000643	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.18e-05	0.000641	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-B—acquired immunodeficiency syndrome	2.16e-05	0.000637	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.15e-05	0.000632	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.13e-05	0.000627	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	2.11e-05	0.000621	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	2.09e-05	0.000617	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.06e-05	0.000608	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	2.06e-05	0.000607	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.97e-05	0.000582	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	1.97e-05	0.00058	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	1.96e-05	0.000577	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	1.95e-05	0.000574	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.000572	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.000572	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000571	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.94e-05	0.000571	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CCR2—acquired immunodeficiency syndrome	1.89e-05	0.000556	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.82e-05	0.000537	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.82e-05	0.000537	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.82e-05	0.000537	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.81e-05	0.000533	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.79e-05	0.000528	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000526	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	1.74e-05	0.000512	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNA1—acquired immunodeficiency syndrome	1.7e-05	0.0005	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD79A—acquired immunodeficiency syndrome	1.65e-05	0.000486	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.65e-05	0.000486	CbGpPWpGaD
Docetaxel—EGFR—Disease—CXCR4—acquired immunodeficiency syndrome	1.64e-05	0.000482	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.62e-05	0.000476	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00047	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.56e-05	0.00046	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.54e-05	0.000455	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.54e-05	0.000452	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.52e-05	0.000447	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000435	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.47e-05	0.000433	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000429	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.35e-05	0.000397	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40LG—acquired immunodeficiency syndrome	1.34e-05	0.000396	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—acquired immunodeficiency syndrome	1.34e-05	0.000394	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.34e-05	0.000393	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—acquired immunodeficiency syndrome	1.33e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.31e-05	0.000386	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—acquired immunodeficiency syndrome	1.29e-05	0.00038	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-B—acquired immunodeficiency syndrome	1.28e-05	0.000377	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.26e-05	0.000371	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.24e-05	0.000366	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.22e-05	0.000359	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.2e-05	0.000353	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.19e-05	0.000352	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000351	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—acquired immunodeficiency syndrome	1.19e-05	0.00035	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.15e-05	0.000338	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.15e-05	0.000338	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—acquired immunodeficiency syndrome	1.12e-05	0.000331	CbGpPWpGaD
Docetaxel—EGFR—Disease—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000331	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.07e-05	0.000316	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.02e-05	0.000299	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	1.01e-05	0.000296	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—acquired immunodeficiency syndrome	9.95e-06	0.000293	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.73e-06	0.000257	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.59e-06	0.000253	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—acquired immunodeficiency syndrome	8.03e-06	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—acquired immunodeficiency syndrome	7.91e-06	0.000233	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.86e-06	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.69e-06	0.000226	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—acquired immunodeficiency syndrome	7.63e-06	0.000225	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	7.48e-06	0.00022	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.22e-06	0.000213	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	7.11e-06	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.09e-06	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—acquired immunodeficiency syndrome	7.05e-06	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—acquired immunodeficiency syndrome	7.02e-06	0.000207	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—acquired immunodeficiency syndrome	6.98e-06	0.000206	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	6.87e-06	0.000202	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	6.25e-06	0.000184	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	6.2e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.54e-06	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.52e-06	0.000133	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.48e-06	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—acquired immunodeficiency syndrome	4.13e-06	0.000122	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	4.04e-06	0.000119	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—acquired immunodeficiency syndrome	3.81e-06	0.000112	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.38e-06	9.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.67e-06	7.86e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.08e-06	6.14e-05	CbGpPWpGaD
